162 related articles for article (PubMed ID: 6332753)
1. Thyrogastric autoimmunity and MHC associated alleles at the C4 locus in patients with type 1 (insulin-dependent) diabetes.
McCann VJ; McCluskey J; Kelly H; Kay PH; Zilko PJ; Christiansen FT; Dawkins RL
Diabetologia; 1984 Jul; 27 Suppl():124-5. PubMed ID: 6332753
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility to IDDM is marked by MHC supratypes rather than individual alleles.
Kelly H; McCann VJ; Kay PH; Dawkins RL
Immunogenetics; 1985; 22(6):643-51. PubMed ID: 3865895
[TBL] [Abstract][Full Text] [Related]
3. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphism of the fourth component of complement and type 1 (insulin-dependent) diabetes.
Marcelli-Barge A; Poirier JC; Schmid M; Deschamps I; Lestradet H; Prevost P; Hors J
Diabetologia; 1984 Jul; 27 Suppl():116-7. PubMed ID: 6332752
[TBL] [Abstract][Full Text] [Related]
5. HLA and complement allotypes in Type 1 (insulin-dependent) diabetes.
McCluskey J; McCann VJ; Kay PH; Zilko PJ; Christiansen FT; O'Neill GJ; Dawkins RL
Diabetologia; 1983 Mar; 24(3):162-5. PubMed ID: 6573286
[TBL] [Abstract][Full Text] [Related]
6. [HLA typing and insulin antibody production in insulin-dependent diabetics].
Bruni B; Barolo P; Gadaleta G; Gamba Ansaldi S; Grassi G; Zerbinati A; Molinatti M; Salvetti E
Ann Osp Maria Vittoria Torino; 1984; 27(7-12):185-213. PubMed ID: 6443704
[TBL] [Abstract][Full Text] [Related]
7. Class III gene rearrangements in Thai/Chinese supratypes containing null or defective C4 alleles.
Kay PH; Martin E; Dawkins RL; Charoenwong P
Immunogenetics; 1988; 27(1):46-50. PubMed ID: 3334723
[TBL] [Abstract][Full Text] [Related]
8. Organ-specific autoimmunity and HLA-DR antigens as markers for beta-cell destruction in patients with type II diabetes.
Groop L; Miettinen A; Groop PH; Meri S; Koskimies S; Bottazzo GF
Diabetes; 1988 Jan; 37(1):99-103. PubMed ID: 3275559
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of human leukocyte antigen class II typing for the development of islet autoantibodies and insulin-dependent diabetes postpartum in women with gestational diabetes.
Ferber KM; Keller E; Albert ED; Ziegler AG
J Clin Endocrinol Metab; 1999 Jul; 84(7):2342-8. PubMed ID: 10404800
[TBL] [Abstract][Full Text] [Related]
10. Are thyrogastric autoantibodies associated with an increased susceptibility to developing type 1 (insulin-dependent) diabetes? A study in identical twins.
Johnston C; Millward BA; Leslie RD; Pyke DA; Bottazzo GF
Autoimmunity; 1990; 6(3):195-201. PubMed ID: 2129777
[TBL] [Abstract][Full Text] [Related]
11. The susceptibility to insulin-dependent diabetes mellitus is associated with C4 allotypes independently of the association with HLA-DQ alleles in HLA-DR3,4 heterozygotes.
Thomsen M; Mølvig J; Zerbib A; de Preval C; Abbal M; Dugoujon JM; Ohayon E; Svejgaard A; Cambon-Thomsen A; Nerup J
Immunogenetics; 1988; 28(5):320-7. PubMed ID: 3139557
[TBL] [Abstract][Full Text] [Related]
12. HLA antigens and complotypes in insulin-dependent diabetes mellitus.
Partanen J; Koskimies S; Ilonen J; Knip M
Tissue Antigens; 1986 May; 27(5):291-7. PubMed ID: 3460220
[TBL] [Abstract][Full Text] [Related]
13. Complement and HLA. Further definition of high-risk haplotypes in insulin-dependent diabetes.
Rich S; O'Neill G; Dalmasso AP; Nerl C; Barbosa J
Diabetes; 1985 May; 34(5):504-9. PubMed ID: 3987976
[TBL] [Abstract][Full Text] [Related]
14. C4 Chido 3 and 6 distinguish two diabetogenic haplotypes: HLA-B49, SC01,DR4,DQw8 and B8,SC01,DR3,DQw2.
Segurado OG; Giles CM; Iglesias-Casarrubios P; Corell A; Martinez-Laso J; Vicario JL; Arnaiz-Villena A
Immunobiology; 1991 Sep; 183(1-2):12-22. PubMed ID: 1682241
[TBL] [Abstract][Full Text] [Related]
15. Rearrangement of 21-hydroxylase genes in disease-associated MHC supratypes.
Garlepp MJ; Wilton AN; Dawkins RL; White PC
Immunogenetics; 1986; 23(2):100-5. PubMed ID: 3007340
[TBL] [Abstract][Full Text] [Related]
16. HLA and GM in insulin-dependent diabetes in the Netherlands: report on a combined multiplex family and population study.
de Jongh BM; Bruining GJ; Schreuder GM; Schuurman RK; Radder JK; van Loghem E; Meera Khan P; Hauptmann G; van Rood JJ
Hum Immunol; 1984 May; 10(1):5-21. PubMed ID: 6586708
[TBL] [Abstract][Full Text] [Related]
17. MHC supratypes as markers of null and defective C4 alleles in a Thai/Chinese population: relevance to disease susceptibility.
Kay PH; Grimsley G; Dawkins RL; Charoenwong P
Dis Markers; 1987 Mar; 5(1):43-7. PubMed ID: 3502980
[TBL] [Abstract][Full Text] [Related]
18. Major histocompatibility complex (MHC) complement deficiency, ancestral haplotypes and systemic lupus erythematosus (SLE): C4 deficiency explains some but not all of the influence of the MHC.
Christiansen FT; Zhang WJ; Griffiths M; Mallal SA; Dawkins RL
J Rheumatol; 1991 Sep; 18(9):1350-8. PubMed ID: 1757937
[TBL] [Abstract][Full Text] [Related]
19. Specific association of HLA-DR4 with increased prevalence and level of insulin autoantibodies in first-degree relatives of patients with type I diabetes.
Ziegler R; Alper CA; Awdeh ZL; Castano L; Brink SJ; Soeldner JS; Jackson RA; Eisenbarth GS
Diabetes; 1991 Jun; 40(6):709-14. PubMed ID: 2040387
[TBL] [Abstract][Full Text] [Related]
20. Polymorphism of the fourth component of complement in Graves' disease and type I diabetes mellitus.
Skanes V; Larsen B; Sampson-Murphy L; Farid NR
Clin Invest Med; 1985; 8(2):126-32. PubMed ID: 3869086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
